We also noted that PROSER1 alterations, including missense, splice site, and frameshift mutations, have been identified in various hematological malignancies of both myeloid and lymphoid origin, albeit at much lower frequencies than TET2 mutations (Figure 1E-F). This evidence concerns the gene TET2 and hematologic disorder.